BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23225851)

  • 1. Combining proteomics, serum biomarkers and bioinformatics to discriminate between esophageal squamous cell carcinoma and pre-cancerous lesion.
    Zhai XH; Yu JK; Lin C; Wang LD; Zheng S
    J Zhejiang Univ Sci B; 2012 Dec; 13(12):964-71. PubMed ID: 23225851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum proteomic profiles of the subjects with esophageal precancerous and cancerous lesions from Linzhou, an area with high incidence of esophageal cancer in Henan Province, Northern China].
    Wang LD; Wang DC; Zheng S; Fan ZM; Li JL; Feng CW; Zhang YR; Liu B; Gao SS; He X; Feng XS
    Ai Zheng; 2006 May; 25(5):549-54. PubMed ID: 16687072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
    Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma.
    Xu SY; Liu Z; Ma WJ; Sheyhidin I; Zheng ST; Lu XM
    Biomarkers; 2009 Aug; 14(5):340-6. PubMed ID: 19552569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
    Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
    Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum proteomic spectra of esophageal squamous cell carcinoma patients analyzed with IMAC3 protein chip].
    Liu CZ; Zhu PY; Shi MX; Liu JB; Liao P; Xiang CQ; Zhang YX; Wang WJ
    Ai Zheng; 2008 Mar; 27(3):272-8. PubMed ID: 18334116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study.
    Fan NJ; Gao CF; Wang XL
    OMICS; 2013 Apr; 17(4):215-23. PubMed ID: 23496306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of serum peptidome patterns of esophageal squamous cell carcinoma patients for comprehensive treatment.
    Wan QL; Hou XS; Zhao G
    Asian Pac J Cancer Prev; 2013; 14(5):2919-23. PubMed ID: 23803054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment of a diagnostic model of serum protein fingerprint pattern for esophageal cancer screening in high incidence area and its clinical value].
    Wang SJ; Zhang LW; Yu WF; Yu JK; Zheng S; Li YS; Er LM; Wen DG; Gao JH
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):441-3. PubMed ID: 17974279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.
    Jia K; Li W; Wang F; Qu H; Qiao Y; Zhou L; Sun Y; Ma Q; Zhao X
    Oncotarget; 2016 Apr; 7(17):23569-80. PubMed ID: 26993605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
    Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
    Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
    Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
    Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.
    Zhang C; Wang C; Chen X; Yang C; Li K; Wang J; Dai J; Hu Z; Zhou X; Chen L; Zhang Y; Li Y; Qiu H; Xing J; Liang Z; Ren B; Yang C; Zen K; Zhang CY
    Clin Chem; 2010 Dec; 56(12):1871-9. PubMed ID: 20943850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
    Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
    Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma.
    Adams L; Roth MJ; Abnet CC; Dawsey SP; Qiao YL; Wang GQ; Wei WQ; Lu N; Dawsey SM; Woodson K
    Cancer Prev Res (Phila); 2008 Oct; 1(5):357-61. PubMed ID: 19137073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum peptidome patterns for early screening of esophageal squamous cell carcinoma.
    Fan NJ; Gao CF; Zhao G; Wang XL; Qiao L
    Biotechnol Appl Biochem; 2012; 59(4):276-82. PubMed ID: 23586861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
    Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
    Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma.
    Couch G; Redman JE; Wernisch L; Newton R; Malhotra S; Dawsey SM; Lao-Sirieix P; Fitzgerald RC
    Cancer Prev Res (Phila); 2016 Jul; 9(7):558-66. PubMed ID: 27072986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS.
    Wang X; Peng Y; Xie M; Gao Z; Yin L; Pu Y; Liu R
    Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28493612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.